Patients Are Currently Criticizing Mast Labs For Long Waiting Periods
参考文献：A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction.
MAST E 200 – HUMAN-LABS
